MiMedx Group, Inc MDXG
$3.91
-0.51%
at last close
Analyst Consensus
- Consensus Rating
- Buy (5 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $8.40
- Implied Upside
- +114.8%
- Price Target Range
- $6.00 – $10.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-27 | Craig-HallumChase Knickerbocker |
Maintains | Buy | $6 → $8 |
| 2026-08-17 | Cantor FitzgeraldSarah James |
Reiterates | Overweight | $8 |
| 2026-04-30 | CitizensDavid Turkaly |
Maintains | Market outperform | $7 → $6 |
| 2026-04-20 | CitizensDavid Turkaly |
Maintains | Market outperform | $10 → $7 |
| 2026-04-17 | Craig-HallumChase Knickerbocker |
Maintains | Buy | $10 → $7 |
| 2026-02-23 | CitizensDavid Turkaly |
Initiates coverage on | Market outperform | $10 |
| 2026-02-17 | Cantor FitzgeraldSarah James |
Maintains | Overweight | $12 → $8 |
| 2026-01-20 | Lake StreetBrooks O'Neil |
Maintains | Buy | $12 → $10 |
| 2025-12-17 | MizuhoAnthony Petrone |
Maintains | Outperform | $12 → $10 |
| 2025-07-31 | Cantor FitzgeraldRoss Osborn |
Maintains | Overweight | $11 → $12 |
| 2025-07-15 | Cantor FitzgeraldRoss Osborn |
Reiterates | Overweight | $11 |
| 2025-02-27 | Cantor FitzgeraldRoss Osborn |
Reiterates | Overweight | $13 |
| 2024-08-01 | Cantor FitzgeraldRoss Osborn |
Reiterates | Overweight | $11 |
| 2024-08-01 | Craig-HallumChase Knickerbocker |
Maintains | Buy | $14 → $12 |
| 2024-07-02 | Cantor FitzgeraldRoss Osborn |
Initiates coverage on | Overweight | $11 |
| 2024-05-01 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $11 |
| 2024-03-07 | Lake StreetBrooks O'Neil |
Initiates coverage on | Buy | $12 |
| 2024-03-01 | MizuhoAnthony Petrone |
Maintains | Buy | $13 → $14 |
| 2023-10-31 | MizuhoAnthony Petrone |
Maintains | Buy | $14 → $12 |
| 2023-10-27 | Craig-HallumChase Knickerbocker |
Initiates coverage on | Buy | $12 |
| 2023-08-02 | MizuhoAnthony Petrone |
Maintains | Buy | $10 → $12 |
| 2023-08-02 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $8 → $11 |
| 2023-06-21 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $10 → $8 |
| 2023-05-03 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $8 → $10 |
| 2023-03-02 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $8 |
| 2022-10-13 | MizuhoAnthony Petrone |
Initiates coverage on | Buy | $7 |
| 2022-09-07 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $9 → $8 |
| 2021-09-14 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $20 → $9 |
| 2021-07-26 | Northland Capital MarketsCarl Byrnes |
Initiates coverage on | Outperform | $23 |
| 2021-03-19 | HC Wainwright & Co.Swayampakula Ramakanth |
Initiates coverage on | Buy | $20 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $3.91
- Market Cap
- $570.60 million
- 52-Week Range
- $3.02 – $7.97
- Average Volume
- 1.34 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.